Role of ranolazine in the prevention and treatment of atrial fibrillation: A meta-analysis of randomized clinical trials
Mengqi Gong(Central South University), Tong Liu(Second Hospital of Tianjin Medical University), Nikolaos Fragakis(Ippokrateio General Hospital of Thessaloniki), Gan‐Xin Yan, Panagiotis Korantzopoulos(University of Ioannina), Guangping Li(Qingdao University), Zhiwei Zhang(Second Hospital of Tianjin Medical University), Κonstantinos P. Letsas(Evangelismos Hospital)
Cited by 39
Related Papers
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
|Journal of the American College of Cardiology|2019|494
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
|Nature Medicine|2016|393
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
|Cardiovascular Diabetology|2019|296
Association Between C-Reactive Protein and Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion
|Journal of the American College of Cardiology|2007|271